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1. Introduction 
Rifamycin and its derivatives are strong inhibitors 
of RNA synthesis in bacteria but not in the nuclei of 
animal cells [l-3] . It has been shown that the anti- 
biotic binds to the bacterial DNA-dependent RNA 
polymerase, thereby interfering with the process of 
chain intiation [4-61 . The sensitivity or insensiti- 
vity of RNA synthesis towards rifamycin isthere- 
fore a property of the respective enzymes. This dis- 
tinguishes rifamycin from other antibiotic inhibitors 
of RNA synthesis, such as actinomycin, which are 
known to react with the DNA template rather than 
with the polymerase. 
In this communication we report studies on the 
effect of rifampicin, a highly potent rifamycin deri- 
va.tive, on the synthesis of RNA catalyzed by cellular 
extracts as well as by a partially purified preparation 
of DNA-dependent RNA polymerase from the yeast, 
Saccharomyces cerevisiae. In addition, we have exa- 
mined the influence of the antibiotic on the RNA 
synthesis in isolated and highly purified yeast mito- 
chondria. Rifamycin was found to be without effect 
on these reactions, even at concentrations as high as 
50 pg/ml. 
2. Materials and methods 
The haploid, wild type strain D273-10 B and a 
locally isolated diploid strain of S. cerevisiae was used. 
Cells were grown to late log phase in a medium con- 
taining 0.5% peptone, 0.3% yeast extract and 1% 
glucose. They were disrupted mechanically and the 
mitochondria were collected by centrifugation and 
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purified by flotation in urografin gradients as des- 
cribed earlier [7,8]. Since yeast nuclei are destroyed 
during homogeniz+tion, the mitochondria-free cell 
extract contains most of the “nuclear” RNA poly- 
merase activity in a soluble form. The enzyme was 
partially purified by fractionation with protamine 
sulfate and ammonium sulfate according to the pro- 
cedure @f Frederick, Maitra and Hurwitz [9] . 
E. coli B was grown in nutrient broth and extracts 
were prepared as described by Maitra and Hurwitz 
[lo] . A highly purified preparation of RNA polymer- 
ase from E. coli K12 was kindly donated by Dr. H. 
Sterbach, Gottingen. 
The reaction mixture for the determination of 
RNA polymerase activity contained: 50 mM tris HCI 
(pH 7.5); 1 mM EDTA, 2 mM P-mercaptoethanol, 50 
r.llw each of ATP, GTP, CTP and UTP, 2 &i/ml 3H- 
UTP (Schwarz BioResearch Inc., specific activity 
2.0 Ci/mmole), 4.2 mM phosphoenolpyruvate, 100 
pg/ml pyruvate kinase, 100 I.cg/ml calf thymus DNA 
(native or denatured, as indicated), 10 mM MgCl, 
or 1.7 mM MnCl, and enzyme. Incubation mixtures 
of 1 .O ml were used for the estimation of RNA poly- 
merase activity in mitochondria or in crude cell ex- 
tracts. After incubation for 15 min at 35’C, samples 
were cooled in ice, precipitated with 5% TCA and 
processed further as described earlier [7] (method 
A). For the purified enzyme preparations a simpler 
procedure was used: mixtures of a total volume of 
0.125 ml were prepared and incubated as above. 100 
~1 aliquots were then removed and applied to discs 
(25 mm in diameter) of Whatman 3MM filter paper 
which were further treated according to the procedure 
of Bollum [ 1 l] (method B). 
Samples of rifampicin were kindly donated by Ciba 
Ltd., Basel. 
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3. Results and discussion 
Fig. 1 summarizes our results. As a control, we 
have employed the DNA-dependent RNA polymerase 
from E. coli. This enzyme is inhibited very strongly by 
rifampicin, being nearly completely inactive in the 
presence of 1 I.cgJml of the antibiotic (curve a). Curve 
b shows the effect of rifampicin on the polymerase ac- 
Fig. 1. Effect of rifampicin on the synthesis of RNA catalyzed 
by RNA polymerases from E. coli and yeast. RNA polymer- 
ase activity was measured as described in Materials and met- 
hods. Rifampicin was added to the incubation mixtures to 
yield the fii concentrations hown in the abscissa. For the 
particular experiments reported here, the following condi- 
tions were used: Purified E. coli RNA polymerase (curve a): 
Determinations were done according to method B. Assay mix- 
tures contained native DNA as template, Mg2+ as divalent ca- 
tion and 2 @ enzyme. 100% activity was equivalent o 64 
pmoles UMP incorporated. E. coli extract: (curve b): Deter- 
minations were done according to method B. No.DNA was 
added, assay mixtures contained Mg2+ and 130 fig protein. 
100% activity was equivalent o 85 pmoles UMP incorporated. 
Partially purified yeast RNA polymerase (curve c): Determi- 
nations were done according to method B. Assay mixtures 
contained denatured DNA as template, Mn2+ as divalent ca- 
tion and 40 pg enzyme. 100% activity was equivalent o 119 
pmoles UMP incorporated. Yeast extract (curve d): Determi- 
nations were done according to method A. Assay mixtures 
contained denatured DNA, Mn 2+ and 1.9 mg protein. 100% ac- 
tivity was equivalent o 175 pmoles UMP incorporated. Yeast 
mitochondria (curve e): Determinations were done according 
to nethod A. No DNA was added because mitochondrial DNA 
serves as template in intact mitochondria [7]. Assay mix- 
tures contained Mg2+ and 2.3 mg protein. 100% activity 
was equivalent o 116 pmole UMP incorporated. 
tivity measured in the crude cellular extract of E. coli. 
Here RNA synthesis i  completely independent of ex- 
ternally added DNA apparently because the enzyme 
is still saturated with cellular (E. coli) DNA. Never- 
theless, an inhibition of about 70% is achieved by the 
addition of rifampicin. This indicates that also in this 
case the synthesis of new RNA chains is initiated 
throughout the incubation time of our assay. 
The yeast RNA polymerase, in contrast, is not in- 
hibited by rifampicin at concentrations as high as 50 
~/ml, regardless of whether a partially purified en- 
zyme preparation (curve c) or the crude cell extract 
(curve d) is used. Enzyme activity is in both cases 
completely dependent on externally added DNA, 
denatured DNA being much more effective in promot- 
ing RNA synthesis than native DNA. Rifampicin in- 
sentivity, however, is not affected by the kind of DNA 
used as template, nor by the replacement of Mn2+ by 
Mg2+ in the assay mixture. A preincubation of the 
enzyme preparation with rifampicin (50 pg/ml) for 2 
min in the absence of the triphosphates does not 
reduce the activity of the polymerase. 
A second point of interest concerned the synthesis 
of RNA in isolated and highly purified yeast mito- 
chondria. We found that this process again was not 
affected by rifampicin (curve e). We consider the pos- 
sibility that rifampicin cannot penetrate the mitochon- 
drial membrane unlikely because the mitochondria 
used were highly swollen. This is evident from the fact, 
that they are, for instance, permeable to actinomycin, 
D, which at a concentration of 50 &ml caused a 90% 
inhibition of RNA synthesis. In spite of numerous 
trials, we have not yet been able to solubilize the mito- 
chondrial RNA polymerase. The enzyme appears to be 
fiily bound to the inner membrane and severe des- 
truction of this membrane destroys the enzyme acti- 
vity. After mild mechanical distintegration of mito- 
chrondria with an Ultra-Turrax homogenizer, a vari- 
able amount of RNA polymerase activity is still mea- 
surable. No inhibition of UMP incorporation is ob- 
served upon addition of rifampicin to such a prepara- 
tion. Even a preincubation of mitochondria with 50 
&ml rifampicin prior to the addition of the triphos- 
phates does not reduce their RNA synthesizing acti- 
vity. 
Experiments with rat liver mitochondria which had 
been swollen by treatment with phosphate or with 
digitonin [ 121 gave identical results; no inhibition of 
RNA synthesis i  obtained. 
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Our experiments are consistent with but do not 
prove the assumption that the mitochondrial RNA 
polymerase is not sensitive to rifampicin. Even if fao 
tors other than the insensitivity of the mitochondrial 
enzyme are responsible for our observations, the mere 
fact that RNA synthesis in isolated mitochondria, in 
contrast to bacterial RNA synthesis, is not affected by 
rifampicin, is of interest. In this respect the rifamycins 
obviously contrast to other antibiotics, such as chlo- 
ramphenicol or erythromycin, which interfere with bac- 
terial protein synthesis. Although these substances 
have no effect on cytoplasmic protein synthesis in 
eukaryotic cells, they do block the corresponding pro- 
cesses in the mitochondria [13-l 51. For the use of 
rifamycin as a drug it may therefore be important to 
known that RNA synthesis in both, nuclei and mito- 
chondria, is not inhibited by this antibiotic. 
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